Abstract
Simvastatin (SV) is a semisynthetic derivative of lovastatin (LV), which is biosynthetically produced from the fungus Aspergillus terreus and has a high log p value (log p = 4.39)and thus high hepatic extraction and high efficacy in controlling cholesterol synthesis. The current study was undertaken to investigate the metabolic profile of SV using various mass spectrometry (MS) platforms. Metabolic profiling was studied in in vitro models, rat liver microsomes (RLMs), and isolated perfused rat liver hepatocytes (RLHs) using both ion trap and triple quadruple LC–MS/MS systems. A total of 29 metabolites were identified. Among them, three types of SV-related phase-I metabolites, namely exomethylene simvastatin acid (exomethylene SVA), monohydroxy SVA, and dihydrodiol SVA, were identified as new in RLMs. No phase-II metabolites were identified while incubating with RLHs.
Funder
Deanship of Scientific Research at King Saud University
Subject
Filtration and Separation,Analytical Chemistry
Reference52 articles.
1. Applications of mass spectrometry in drug metabolism: 50 years of progress;Wen;Drug Metab. Rev.,2015
2. Drug metabolism in drug discovery and development;Zhang;Acta Pharm. Sin. B,2018
3. Lee, M.S., and Zhu, M. (2011). Mass Spectrometry in Drug Metabolism and Disposition: Basic Principles and Applications, John Wiley & Sons, Inc. [1st ed.].
4. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes;Obach;Drug Metab. Dispos.,1999
5. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes;Carlile;Drug Metab. Dispos.,1998
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献